These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1349507)

  • 41. Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
    Zhang XY; Yu YQ; Sun S; Zhang X; Li W; Xiu MH; Chen DC; Yang FD; Zhu F; Kosten TA; Kosten TR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1765-9. PubMed ID: 21723906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
    Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
    Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.
    Sweet RA; Mulsant BH; Gupta B; Rifai AH; Pasternak RE; McEachran A; Zubenko GS
    Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia.
    Modestin J; Stephan PL; Erni T; Umari T
    Schizophr Res; 2000 May; 42(3):223-30. PubMed ID: 10785580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia.
    Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T
    Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tardive dyskinesia in schizophrenics under 60 years of age.
    Kolakowska T; Williams AO; Ardern M; Reveley MA
    Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacy-based screening program for tardive dyskinesia.
    Ahrens TN; Sramek JJ; Herrera JM; Jewett CM; Alcorn VE
    Drug Intell Clin Pharm; 1988 Mar; 22(3):205-8. PubMed ID: 2896586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
    Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
    J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tardive dyskinesia: who is at risk?
    van Os J; Fahy T; Jones P; Harvey I; Toone B; Murray R
    Acta Psychiatr Scand; 1997 Sep; 96(3):206-16. PubMed ID: 9296552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
    Altamura AC; Cavallaro R; Regazzetti MG
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroleptic-induced tardive dyskinesia among Arab psychotic patients.
    Osman A; Marghalani M; Turkistani IY; Al-Swaf M; Bin Sadiq B
    East Mediterr Health J; 2007; 13(3):625-32. PubMed ID: 17687836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal.
    Kirch D; Hattox S; Bell J; Murphy R; Freedman R
    Psychiatry Res; 1983 Jul; 9(3):217-23. PubMed ID: 6137850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of and risk factors for respiratory dyskinesia.
    Hayashi T; Nishikawa T; Koga I; Uchida Y; Yamawaki S
    Clin Neuropharmacol; 1996 Oct; 19(5):390-8. PubMed ID: 8889282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.
    Huang Y; Pan L; Teng F; Wang G; Li C; Jin L
    Shanghai Arch Psychiatry; 2017 Oct; 29(5):295-303. PubMed ID: 29276353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gender differences in tardive dyskinesia: a critical review of the literature.
    Yassa R; Jeste DV
    Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.